Originally published by our sister publication Infectious Disease Special Edition
By Marie Rosenthal, MS
The CDC’s Advisory Committee on Immunization Practices recommended that the mpox vaccine Jynneos, by Bavarian Nordic, be added to the routine vaccination schedule for certain adults who are at high risk for acquiring the disease.
The recommendation, for those ages 18 years and older, is an interim recommendation that the committee will revisit in two to three years. Groups at risk include